Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SGMO will decline by -26.09% over the next 2 Weeks and hit $0.09 by Thursday, May 14, 2026. In that time frame, SGMO's share price is expected to range between $0.06 and $0.11.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 14, 2026 | 0.06 | 0.09 | 0.11 |
| May 13, 2026 | 0.07 | 0.09 | 0.11 |
| May 12, 2026 | 0.06 | 0.09 | 0.11 |
| May 11, 2026 | 0.07 | 0.09 | 0.12 |
| May 8, 2026 | 0.07 | 0.09 | 0.12 |
| May 7, 2026 | 0.09 | 0.11 | 0.13 |
| May 6, 2026 | 0.09 | 0.11 | 0.13 |
| May 5, 2026 | 0.08 | 0.10 | 0.13 |
| May 4, 2026 | 0.09 | 0.11 | 0.13 |
| May 1, 2026 | 0.09 | 0.11 | 0.13 |
SGMO shares rose +13.26% in Friday, May 1, 2026's trading session, rising from a previous close of $0.12 to move at $0.14. The stock demonstrated notable intraday movement (see SGMO's key stats for a full breakdown), fluctuating between $0.12 and $0.14, a +16.27% trading range. While recent weeks have seen some volatility, SGMO has managed to secure a -50.00% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 24.24M shares changing hands, 24.33M fewer than the previous session. This amounted to $3.27M in total market activity.
Will SGMO Continue Its Downward Trend?
According to analyst ratings and projections for SGMO, Sangamo Therapeutics, Inc. shares are anticipated to decrease by -23.21%, potentially reaching $0.11 per share by May 14, 2026. Short-term technical indicators for SGMO currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the SGMO stock forecast, now is not the best time to buy SGMO stock because its current trading price is +53.23% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on SGMO covering social and institutional perspectives.
SGMO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SGMO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 24.96% to 30.32%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 38.14%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 42.93%, maintains a neutral outlook for the long term. Insights into SGMO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Sangamo Therapeutics Short-Term Forecasts
SGMO Forecast For Next 5 Days
Our algorithm anticipates Sangamo Therapeutics (SGMO) stock could hit $0.18 by May 08, 2026. This represents a +34.74% fall from today's price, following a -18.49% change over the past five days.
SGMO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Sangamo Therapeutics, Inc. (SGMO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.15, which would mean a +11.11% increase from the current price of $0.14. Projections for this period range from a high of $0.23 to a low of $0.07.
SGMO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Sangamo Therapeutics's price over the next three months point to a rise. SGMO stock is expected to peak at $1.57 on Jul 20, 2026 after potentially dipping to $0.69 on May 07, 2026. On average, SGMO is likely to trade around $1.22 in the coming 90 days.
Sangamo Therapeutics Stock Forecast 2025
Based on our predictive models, Sangamo Therapeutics (SGMO) is expected to trade between $0.00 and $1.61 throughout 2026. This would result in an average price of $1.23, potentially offering investors a +811.11% return from current levels.
Sangamo Therapeutics, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Sangamo Therapeutics, Inc. (SGMO) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.69 and $1.18, settling at an average of $0.87. This could translate to a +544.44% gain.
June 2026
Based on current market signals, Sangamo Therapeutics, Inc. is projected to trend june 2026. We forecast a trading range from $1.10 to $1.54, with a likely average price of $1.32. Investors could expect a potential return of +877.78%.
July 2026
Our predictive algorithms indicate Sangamo Therapeutics, Inc. stock may see a shift in July 2026. The expected range spans $1.21–$1.57, with an average target of $1.44. This represents a positive outlook and a possible gain of +966.67%.
August 2026
Analyzing established trends, Sangamo Therapeutics, Inc. looks set to move in August 2026. Projections place the stock between $1.01 and $1.61, averaging around $1.46. This suggests a +981.48% gain from current levels.
September 2026
Market indicators suggest Sangamo Therapeutics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.43 to $1.41, with a midpoint forecast of $1.16. The stock might deliver a +759.26% gain.
October 2026
Forecasting for October 2026, models estimate that Sangamo Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.26 and $1.17, averaging $0.81. This signals a positive trajectory with potential returns around +500.00%.
November 2026
According to our latest forecast models, Sangamo Therapeutics, Inc. (SGMO) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.03 and $1.61, settling at an average of $1.46. This could translate to a +981.48% gain.
December 2026
Based on current market signals, Sangamo Therapeutics, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $0.96, with a likely average price of $1.26. Investors could expect a potential return of +833.33%.
January 2027
Our predictive algorithms indicate Sangamo Therapeutics, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$0.59, with an average target of $0.86. This represents a positive outlook and a possible gain of +537.04%.
February 2027
Analyzing established trends, Sangamo Therapeutics, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $0.20, averaging around $0.99. This suggests a +633.33% gain from current levels.
March 2027
Market indicators suggest Sangamo Therapeutics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.64. The stock might deliver a +374.07% gain.
April 2027
Forecasting for April 2027, models estimate that Sangamo Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.52. This signals a positive trajectory with potential returns around +285.19%.
SGMO's history of dividends and stock splits also plays a role in long-term investor confidence.

